ESCRS Homepage

April 2003
Eye to Eye Supplement Compliance : The Hidden Challenge of Glaucoma Management
IN THIS ISSUE

Safer refractive IOLs to boost vision options for ametropes


EGS to publish updated guidelines for diagnosis and management of glaucoma

Topical beta-blockers cause respiratory obstruction for one in every 55 patients

Immediate treatment halves risk of open-angle glaucoma progression, EMGT report reveals

Nothing between them as randomised Canadian SLT/ALT study releases preliminary results

Latanoprost does not cause ocular pathology by inducing ultrastructural iris changes, says study

One-piece ‘floating’ refractive implant could prove a secure new option for the correction of myopia

Battlelines clearly marked out as trabeculectomy and drainage implant surgery go head to head

New visual field testing strategies to banish patient boredom and facilitate earlier detection

Latanoprost remains leader of the drops but proponents of competing drugs line up to bid for alternative

Data drought ends as surge of clinical results explains effects of treatments on the development of glaucoma

Zyoptix system produces encouraging results in US for the correction of myopia

Refractive IOL and laser bioptics broaden possibilities for highly ametropic patients, says specialists

How the eye’s natural adaptive mechanism
can compensate for corneal aberrations

Handheld GPS device helps blind steer safely through the metropolitan jungle

New classification system to assist in diagnosis and treatment of limbal stem cell disease

Lasik on top in ultimate test as daredevil climbers reach Mount Everest’s summit in 29,000ft hike

PHMB-containing antiseptics ‘may offer alternative’ to iodine
perioperative agents, say researchers

High intensity headlights could cause road
accidents by dazzling oncoming drivers

Oral sildenafil causes inconsistent changes in
choroidal vascular congestion, study shows

HALTK’s alternative to PK could be gateway to restoring corneal clarity

Doctors warn against ditching specs Superman-style as fears remain on safety of paediatric Lasik

Povidone-iodine offers inexpensive alternative for paediatric conjunctivitis

Getting to grips with ocular tissue is crucial to PK success in children

New device brings virtual vision to the blind

Toric IOLs improve on previous designs with less rotation and more patient satisfaction

FEATURES
From The Editor
Guest Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
Prime Site
An Eye On Travel
Regulatory Matters



From The Editors: By Paul Rosen FRCS, FRCOphth

THIS issue brings together a number of reports on glaucoma management and detection. The news from Clive Migdal MD, that the European Glaucoma Society is to publish an updated "Terminology and Guidelines for Glaucoma" incorporating evidence from a number of international clinical trials is to be welcomed.

Eve Higginbotham’s guest editorial on compliance deals with the perennial problem of why patients don’t use their eye drops regularly. How often and when do your patients use their treatment? For example, I’m always fastidious about telling my patients who are on twice daily medication, to instil them “twelve hourly”. I notice that many patients however are on "bd" regimes.

Last week I asked a patient at what time he was using his bd Timolol and he replied at 1.00pm and 4.00pm! Where patients keep their drops is also important. Those on once “nightly” medication are best keeping their drops either “next to their bed” or “next to their toothbrush.” Patients on latanoprost are often confused about the instructions for long term storage in the refrigerator.

Instructions, however, state that once opened there is no need for refrigeration and therefore patients on this “once nightly” medication may keep their drops next to their bed. Seeing their eye drop bottle as they “get into bed” reminds them to instil their eye drops and improves compliance. There is an additional discussion on the effects of patient non-compliance on the progress of the disease in the insert in this magazine sponsored by Pharmacia.

In this issue you will find details of a request to compile a reader satisfaction survey “on our website”. Please give us 15 minutes of your time to complete this questionnaire. For every reply the ESCRS will make a donation to UNICEF. The answers will help us make an ‘almost perfect’ publication ‘perfect’.

Why do I feel EuroTimes is ‘almost perfect’? because every time I ask for correspondence or criticism of articles/editorials I receive none. Remember that any opinion you send to us for publication will be distributed in 21,000 copies and read by an estimated 60,000 people in 62 countries.

Although EuroTimes is a monthly “throw away” magazine it is archived ‘on the net’ and opinions expressed in its pages are accessible to present and future generations as a representation of contemporary ophthalmology. Please let us have your views as well as our own.

Top